tiprankstipranks
Trending News
More News >
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
US Market
Advertisement

Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?

Compare
647 Followers

Galectin Therapeutics (GALT) Ownership Overview

28.72%4.15%1.11%3.28%62.73%
28.72% Insiders
1.11% Other Institutional Investors
3.28% ETFs
62.73% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 8.55% of the company’s stock is owned by Institutional Investors, 28.72% is owned by Insiders, and 62.73% is owned by Public Companies and Individual Investors.
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 5.26% of the company’s stock is owned by Institutional Investors, 28.72% is owned by Insiders, and 3.28% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 04, 2025
xxxxxxxxxxxxx
$851700
Nov 12, 2025
xxxxxxxxxxxxx
$210000
Oct 24, 2025
xxxxxxxxxxxxx
$246800
Jul 22, 2025
xxxxxxxxxxxxx
$2920

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,328,981Insider16.12%56,912,685
5,832,207Insider9.10%32,135,461
2,102,263Institution3.28%11,583,469
1,899,114Institution2.96%10,464,118
1,045,541Insider1.63%5,760,931
834,592Insider1.30%4,598,602
492,731Institution0.77%2,714,948
147,832Insider0.23%814,554
107,522Institution0.17%592,446
69,107Insider0.11%380,780

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,102,263Institution3.28%11,583,469
492,731Institution0.77%2,714,948
37,318Institution0.06%205,622
26,902Institution0.04%148,230
606Institution<0.01%3,339
289Institution<0.01%1,592
31Institution<0.01%171

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,355,732Institution2.12%5,741,525
543,382Institution0.85%2,301,223
107,522Institution0.17%594,597
51,484Institution0.08%284,707
46,255Institution0.07%255,790

FAQ

Who Owns Galectin Therapeutics Inc (GALT)?
According to the latest TipRanks data, approximately 1.11% of the company's stock is held by institutional investors, 28.72% is held by insiders, and 62.73% is held by retail investors.
    What percentage of Galectin Therapeutics Inc (GALT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.11% of Galectin Therapeutics Inc (GALT) stock is held by institutional investors.
      What percentage of Galectin Therapeutics Inc (GALT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 62.73% of Galectin Therapeutics Inc (GALT) stock is held by retail investors.
        Who owns the most shares of Galectin Therapeutics Inc (GALT)?
        Richard E Uihlein owns the most shares of Galectin Therapeutics Inc (GALT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis